檢索結果 - Wouter Nijkamp

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Telomerase-independent Regulation of ATR by Human Telomerase RNA

    Telomerase-independent Regulation of ATR by Human Telomerase RNA 由 Martijn Kedde, Carlos le Sage, Anja Duursma, Eitan Zlotorynski, Bart van Leeuwen, Wouter Nijkamp, Roderick L. Beijersbergen, Reuven Agami

    出版 2006
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Phosphatidylinositol 3-Kinase Hyperactivation Results in Lapatinib Resistance that Is Reversed by the mTOR/Phosphatidylinositol 3-Kinase Inhibitor NVP-BEZ235

    Phosphatidylinositol 3-Kinase Hyperactivation Results in Lapatinib Resistance that Is Reversed by the mTOR/Phosphatidylinositol 3-Kinase Inhibitor NVP-BEZ235 由 Pieter J.A. Eichhorn, Magüi Gili, Maurizio Scaltriti, Violeta Serra, Marta Guzmán, Wouter Nijkamp, Roderick L. Beijersbergen, Vanesa Valero, Joan Seoane, René Bernards, José Baselga

    出版 2008
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    ZNF423 Is Critically Required for Retinoic Acid-Induced Differentiation and Is a Marker of Neuroblastoma Outcome

    ZNF423 Is Critically Required for Retinoic Acid-Induced Differentiation and Is a Marker of Neuroblastoma Outcome 由 Sidong Huang, Jamila Laoukili, Mirjam T. Epping, Jan Köster, Michael Hölzel, Bart A. Westerman, Wouter Nijkamp, Akiko Hata, Shahab Asgharzadeh, Robert C. Seeger, Rogier Versteeg, Roderick L. Beijersbergen, René Bernards

    出版 2009
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    NF1 Is a Tumor Suppressor in Neuroblastoma that Determines Retinoic Acid Response and Disease Outcome

    NF1 Is a Tumor Suppressor in Neuroblastoma that Determines Retinoic Acid Response and Disease Outcome 由 Michael Hölzel, Sidong Huang, Jan Köster, Ingrid Øra, Arjan Lakeman, Huib N. Caron, Wouter Nijkamp, Jing Xie, Tom Callens, Shahab Asgharzadeh, Robert C. Seeger, Ludwine Messiaen, Rogier Versteeg, René Bernards

    出版 2010
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    A large-scale RNAi screen in human cells identifies new components of the p53 pathway

    A large-scale RNAi screen in human cells identifies new components of the p53 pathway 由 Katrien Berns, E. Marielle Hijmans, Jasper Mullenders, Thijn R. Brummelkamp, Arno Velds, Mike Heimerikx, Ron Kerkhoven, Mandy Madiredjo, Wouter Nijkamp, Britta Weigelt, Reuven Agami, Wei Ge, Guy Cavet, Peter S. Linsley, Roderick L. Beijersbergen, René Bernards

    出版 2004
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling

    MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling 由 Sidong Huang, Michael Hölzel, Theo Knijnenburg, Andreas Schlicker, Paul Roepman, Ultan McDermott, Mathew J. Garnett, Wipawadee Grernrum, Chong Sun, Anirudh Prahallad, Floris H. Groenendijk, Lorenza Mittempergher, Wouter Nijkamp, Jacques Neefjes, Ramón Salazar, Peter ten Dijke, Hidetaka Uramoto, Fumihiro Tanaka, Roderick L. Beijersbergen, Lodewyk F.A. Wessels, René Bernards

    出版 2012
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Loss of <i>ARID1A</i> Activates <i>ANXA1</i>, which Serves as a Predictive Biomarker for Trastuzumab Resistance

    Loss of <i>ARID1A</i> Activates <i>ANXA1</i>, which Serves as a Predictive Biomarker for Trastuzumab Resistance 由 Katrien Berns, Amir Sonnenblick, Annemiek M.C. Gennissen, Sylvain Brohée, E. Marielle Hijmans, Bastiaan Evers, Debora Fumagalli, Christine Desmedt, Sibylle Loibl, Carsten Denkert, Patrick Neven, Wei Guo, Fan Zhang, Theo Knijnenburg, Tjalling Bosse, Michiel S. van der Heijden, Sanne Hindriksen, Wouter Nijkamp, Lodewyk F.A. Wessels, Heikki Joensuu, Gordon B. Mills, Roderick L. Beijersbergen, Christos Sotiriou, René Bernards

    出版 2016
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: